AR023271A1 - POLYMER CONJUGATE ABLE TO INHIBIT ONE OR MORE PROTEOLITICAL ENZYMES - Google Patents

POLYMER CONJUGATE ABLE TO INHIBIT ONE OR MORE PROTEOLITICAL ENZYMES

Info

Publication number
AR023271A1
AR023271A1 ARP000104756A ARP000104756A AR023271A1 AR 023271 A1 AR023271 A1 AR 023271A1 AR P000104756 A ARP000104756 A AR P000104756A AR P000104756 A ARP000104756 A AR P000104756A AR 023271 A1 AR023271 A1 AR 023271A1
Authority
AR
Argentina
Prior art keywords
enzymes
proteolitical
inhibit
polymeric
polymer conjugate
Prior art date
Application number
ARP000104756A
Other languages
Spanish (es)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR023271A1 publication Critical patent/AR023271A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Conjugados poliméricos apropiados para el uso en la prevencion de la irritacion cutánea que se produce por la exposicion de la piel a los fluidoscorporales, inter alia, el fluido menstrual. Conjugados poliméricos que tienen la formula (1), en donde Tes una unidad heterocíclica que es capaz de inhibiruna o más enzimas proteolíticas; L es un grupo de enlace; [Poli] es una unidad polimérica, i representa el numero de dichas unidades heterocíclicas quecomprenden el conjugado y tiene un valor desde1 hasta 100; z es 0 o 1, en donde los conjugados poliméricos. Campo de aplicacion: Panales, rellenos, toallassanitarias y artículos similares.Polymeric conjugates suitable for use in the prevention of skin irritation caused by exposure of the skin to body fluids, inter alia, menstrual fluid. Polymeric conjugates having the formula (1), wherein Tes a heterocyclic unit that is capable of inhibiting one or more proteolytic enzymes; L is a linking group; [Poly] is a polymeric unit, i represents the number of said heterocyclic units that comprise the conjugate and has a value from 1 to 100; z is 0 or 1, where the polymer conjugates. Field of application: Honeycombs, fillings, health class and similar items.

ARP000104756A 1999-09-10 2000-09-11 POLYMER CONJUGATE ABLE TO INHIBIT ONE OR MORE PROTEOLITICAL ENZYMES AR023271A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15341899P 1999-09-10 1999-09-10

Publications (1)

Publication Number Publication Date
AR023271A1 true AR023271A1 (en) 2002-09-04

Family

ID=22547144

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000104756A AR023271A1 (en) 1999-09-10 2000-09-11 POLYMER CONJUGATE ABLE TO INHIBIT ONE OR MORE PROTEOLITICAL ENZYMES
ARP000104757A AR022655A1 (en) 1999-09-10 2000-09-11 COMPOSITIONS TO INHIBIT ENZYMES, APPLICABLE TO HUMAN SKIN AND TO PREVENT SKIN IRRITATION AND METHOD TO PREVENT SKIN IRRITATION.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP000104757A AR022655A1 (en) 1999-09-10 2000-09-11 COMPOSITIONS TO INHIBIT ENZYMES, APPLICABLE TO HUMAN SKIN AND TO PREVENT SKIN IRRITATION AND METHOD TO PREVENT SKIN IRRITATION.

Country Status (9)

Country Link
US (1) US6541629B1 (en)
EP (2) EP1438073B1 (en)
JP (1) JP5020451B2 (en)
AR (2) AR023271A1 (en)
AT (2) ATE309824T1 (en)
AU (2) AU7125700A (en)
DE (2) DE60044827D1 (en)
PE (2) PE20010586A1 (en)
WO (2) WO2001017564A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803496B2 (en) * 1997-09-10 2004-10-12 The Procter & Gamble Company Method for maintaining or improving skin health
US8907154B2 (en) 2001-10-01 2014-12-09 The Procter & Gamble Company Sanitary napkins with hydrophobic lotions
US8795716B2 (en) 2001-10-01 2014-08-05 The Procter & Gamble Company Skin care compositions on a thin sanitary napkin
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
ES2341545T3 (en) * 2003-06-06 2010-06-22 Arexis Ab USE OF CONDENSED HETEROCICLICAL COMPOUNDS AS SCCE INHIBITORS FOR THE TREATMENT OF SKIN DISEASES.
US7384113B2 (en) * 2004-04-19 2008-06-10 Hewlett-Packard Development Company, L.P. Fluid ejection device with address generator
US7642397B2 (en) * 2004-08-10 2010-01-05 Kimberly-Clark Worldwide, Inc. Absorbent articles comprising a bodily exudate modifying agent and a skin care formulation
US7265257B2 (en) * 2004-08-10 2007-09-04 Kimberly-Clark Worldwide, Inc. Absorbent articles comprising a bodily exudate modifying agent and a film-forming skin care formulation
CA2715577A1 (en) * 2008-02-15 2009-08-20 The Proctor & Gamble Company Absorbent article with lotion comprising a polypropylene glycol material
EP2889306B1 (en) * 2012-08-24 2018-09-19 Ajinomoto Co., Inc. Acyl dipeptide derivative
JP7404031B2 (en) 2019-10-29 2023-12-25 日本航空電子工業株式会社 antenna

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211469A1 (en) 1972-12-21 1974-07-19 Air Liquide Enzyme purification, esp. ribonuclease, and (chymo) trypsin - by treatment with specific polyinhibitors and extraction or pptn of the complex formed
DE2433883C2 (en) * 1973-07-20 1986-03-27 Research Corp., New York, N.Y. Use of physiologically active polypeptides
FR2252351A2 (en) 1973-11-28 1975-06-20 Air Liquide Isolation of enzymes by selective extraction - partition of polyinhibitor-enzyme complex between water and polyethylene glycol
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5162307A (en) 1988-09-09 1992-11-10 Board Of Trustees Of The University Of Kentucky Polymer bound elastase inhibitors
FR2651125B1 (en) * 1989-08-23 1992-10-02 Roussel Uclaf PHARMACEUTICAL COMPOSITIONS OF THE "WATER PASTE" TYPE.
EP0452179B1 (en) 1990-03-28 1996-06-12 Nippon Oil And Fats Company, Limited Polymer-combined drug for gastric treatment and a method for producing the drug
JPH04182423A (en) * 1990-11-16 1992-06-30 Shiseido Co Ltd Cleaning and wiping agent composition
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
DE4342154A1 (en) 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalanine derivatives, process for their preparation, their use and agents containing them as anticoagulants
JP3945544B2 (en) * 1995-12-27 2007-07-18 ピジョン株式会社 Method for producing soybean extract
EP0954572A1 (en) * 1997-01-10 1999-11-10 Novo Nordisk A/S Enzyme coupled with polymeric molecules for skin care
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CA2322503A1 (en) * 1998-03-12 1999-09-16 Donald Carroll Roe Disposable absorbent article having a skin care composition containing an enzyme inhibitor
US6066673A (en) * 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
EP1061963B1 (en) * 1998-03-12 2003-05-07 The Procter & Gamble Company Protease inhibitors in absorbent articles
CA2358463A1 (en) 1999-01-08 2000-07-13 Virginia Commonwealth University Polymeric delivery agents and delivery agent compounds
JP2003508480A (en) * 1999-09-10 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー Enzyme inhibitors
WO2001018181A2 (en) * 1999-09-10 2001-03-15 The Procter & Gamble Company Enzyme inhibitors

Also Published As

Publication number Publication date
ATE309824T1 (en) 2005-12-15
EP1212097B1 (en) 2005-11-16
AU7126900A (en) 2001-04-10
DE60024101T2 (en) 2006-07-27
JP5020451B2 (en) 2012-09-05
EP1438073B1 (en) 2010-08-11
WO2001017565A3 (en) 2002-01-17
JP2003508498A (en) 2003-03-04
WO2001017565A2 (en) 2001-03-15
EP1438073A2 (en) 2004-07-21
WO2001017564A2 (en) 2001-03-15
EP1212097A2 (en) 2002-06-12
PE20010586A1 (en) 2001-06-23
DE60024101D1 (en) 2005-12-22
WO2001017564A3 (en) 2002-01-24
ATE476998T1 (en) 2010-08-15
AU7125700A (en) 2001-04-10
US6541629B1 (en) 2003-04-01
DE60044827D1 (en) 2010-09-23
AR022655A1 (en) 2002-09-04
PE20010587A1 (en) 2001-07-07

Similar Documents

Publication Publication Date Title
AR023271A1 (en) POLYMER CONJUGATE ABLE TO INHIBIT ONE OR MORE PROTEOLITICAL ENZYMES
BR9714270A (en) Liquid skin cleansing composition
ES2162029T3 (en) COMPOSITIONS FOR PERSONAL CARE AND PRODUCTS OF FROTAR CLOTHES CONTAINING COMPOSITIONS.
MX272772B (en) FILM FORMATION COMPOSITIONS TO PROTECT THE SKIN FROM BODY FLUIDS AND ARTICLES PREPARED FROM THEMSELVES.
ATE290890T1 (en) WATERFREE, HYDROPHILIC ABSORBENT WOUND DRESSING
BR9916592A (en) Personal care article kidnapping skin irritant and method of kidnapping skin irritants
BR0111358A (en) Thioacetamide compounds and their use
DE69911295D1 (en) Disposable body fluid absorbent articles
ATE16891T1 (en) ABSORBENT FOR BLOOD AND SEROUS BODY FLUIDS.
BR0113751A (en) Cosmetic and pharmaceutical compositions and their uses
DOP2002000383A (en) A TWO-PHASE COSMETIC PRODUCT APPLICABLE WITH A BALL
HRPK990402B1 (en) Pharmaceutical compositions for application to mucosa
PT1091747E (en) USE OF SALT ISOTHERMAL SOLUTIONS FOR THE PREVENTION OF INFLAMMATION
NO20000310L (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use
ATE307625T1 (en) DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF VASCULAR DISEASES
IT1318365B1 (en) PROTECTION DEVICE FOR NEEDLE FOR SYRINGE FOR MEDICAL USE.
ES2068469T3 (en) AGENT FOR THE PROTECTION OF PLANTS AGAINST ATTACK BY MICROORGANISMS.
ATE361757T1 (en) STABLE FUMAGILLIN FORMULATION
WO2002085325A3 (en) Production and use of a suspension composition comprising an ultrasound contrast medium
AR028403A1 (en) DISPOSABLE ABSORBENT INTERIOR GARMENTS TO CONTAIN BODY FLUID
IT1318516B1 (en) OPTICALLY ACTIVE 2-AMINOTETRALINIC DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC USE OF THE CORRESPONDENTS
ES2069803T3 (en) USE OF PIRIDINARY SALTS FOR THE PROTECTION OF PLANTS AGAINST ATTACK BY MICROORGANISMS.
BR0303384A (en) Citalopram And Its Uses In The Treatment Of High Blood Pressure
RU2000123206A (en) CAVITATING ENVIRONMENT IN THE TREATMENT OF RAS
AR028446A1 (en) FORMULATION OF MICROORGANISMS FOR THE FIGHT AGAINST GEL ROEDORS FOR CEBOS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal